BTAI Competitors & Alternatives

Compare BioXcel Therapeutics Inc with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

BTAI

Main Stock
$1.16
Tradestie Score
54
Market Cap
$50.49M
Revenue Growth
0.2%
Analyst Upside
+1106.9%

Top Competitors

47 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
COLL Collegium Pharmaceutical, Inc. Common Stock
$31.06
$1.11B 14.8 57 Compare
CRON Cronos Group Inc. Common Share
$2.71
$1.02B - 59 Compare
ESPR Esperion Therapeutics, Inc.
$3.14
$584.71M - 61 Compare
ETON Eton Pharmaceutcials, Inc. Common Stock
$27.61
$543.32M - 48 Compare
ALLO Allogene Therapeutics, Inc. Common Stock
$2.00
$275.13M - 55 Compare
IRWD Ironwood Pharmaceuticals, Inc. - Class A
$3.24
$237.15M 5.3 52 Compare
BIOA BioAge Labs, Inc. Common Stock
$16.04
$212.23M - 56 Compare
ATRA Atara Biotherapeutics, Inc
$9.63
$101.48M - 56 Compare
KPTI Karyopharm Therapeutics Inc.
$9.00
$53.85M - 58 Compare
KYNB KYNB
$6.81
- - 57 Compare

Data updated: Jun 03, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

47 stocks in this industry